Kim Newton is a Scientist in the Physiological Chemistry Department at Genentech, Inc. Her group's current focus is kinases belonging to the RIPK family and their roles in human disease. She is also involved in collaborative efforts studying the regulation of PEA3 family transcription factors (ETV1, ETV4, and ETV5) by the ubiquitin ligase COP1. Kim joined Genentech as a Postdoctoral Fellow with Vishva Dixit in the Molecular Oncology Department in 2001. She obtained her PhD from the University of Melbourne, Australia after studying cell death regulation in the immune system with Andreas Strasser at the Walter and Eliza Hall Institute.
« Go Back